Nanomaterials for the regulation of the tumor microenvironment and theranostics

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Cancer remains a leading global health threat, with conventional treatments like surgery, chemotherapy, and radiotherapy exhibiting limited efficacy due to complex tumor biology.
• Significant challenges exist in leveraging the tumor microenvironment (TME) differences for targeted therapies and developing nanoplatforms for early cancer diagnosis and non-toxic treatment.

Purpose of the Study:

• To review the latest advancements in multifunctional nanomedicines designed for regulating the tumor microenvironment (TME).
• To discuss the theranostic applications of these nanomedicines in cancer treatment.
• To provide critical insights for the future development of nanomedicine in oncology.

Main Methods:

• Review of current research on multifunctional nanomaterials for cancer theranostics.
• Analysis of nanomedicine strategies for TME modulation, including oxygen generation and reactive oxygen species production.
• Evaluation of nanoplatforms for multi-modal imaging and personalized cancer therapy.

Main Results:

• Multifunctional nanomaterials demonstrate potential in regulating the TME through various mechanisms like oxygen generation and glutathione consumption.
• These nanoplatforms offer capabilities for early diagnosis, effective therapy, and multi-modal imaging in cancer theranostics.
• Personalized therapeutic strategies utilizing nanomedicines show promise in overcoming traditional treatment limitations.

Conclusions:

• Multifunctional nanomedicines represent a promising frontier in cancer theranostics by enabling TME regulation and personalized treatment.
• Further research into nanoplatform design is crucial for advancing non-toxic and effective cancer diagnosis and therapy.
• This review highlights the potential of nanomedicine to address current challenges in oncology and improve patient outcomes.